The story of Viagra, originally marketed by copyright, presents a intricate case study for investors considering the pharmaceutical arena . Despite its early success and creation of countless in earnings , the exclusivity lapse has opened the door for generic medications, significantly eroding income opportunities. This change raises questions abou